Evidence map›Paper›PMID 34845905›Full record

ArticleThe journal of physical chemistry. B2021

Computational Modeling of the Virucidal Inhibition Mechanism for Broad-Spectrum Antiviral Nanoparticles and HPV16 Capsid Segments.

Parth Chaturvedi, Payam Kelich, Tara A Nitka, Lela Vuković

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Sulfoglycodendron Antivirals with Scalable Architectures and Activities.Journal of chemical information and modeling · 2024
    Article
  4. Sulfoglycodendron Antivirals with Scalable Architectures and Activities.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parth ChaturvediDepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, Texas 79968, United States.
Payam KelichDepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, Texas 79968, United States.
Tara A NitkaDepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, Texas 79968, United States.ORCID 0000-0001-9435-6515
Lela VukovićDepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, Texas 79968, United States.ORCID 0000-0002-9053-5708

Funding

Computational modeling of broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanismR03AI142553 · NIAID · UNIVERSITY OF TEXAS EL PASO · PI VUKOVIC, LELA · 2019 to 2020
$151k
NIAID NIH HHS R03 AI142553
6 · The paper itself

Abstract

Solid core nanoparticles (NPs) coated with sulfonated ligands that mimic heparan sulfate proteoglycans (HSPGs) can exhibit virucidal activity against many viruses that utilize HSPG interactions with host cells for the initial stages of infection. How the interactions of these NPs with large capsid segments of HSPG-interacting viruses lead to their virucidal activity has been unclear. Here, we describe the interactions between sulfonated NPs and segments of the human papilloma virus type 16 (HPV16) capsids using atomistic molecular dynamics simulations. The simulations demonstrate that the NPs primarily bind at the interfaces of two HPV16 capsid proteins. After equilibration, the distances and angles between capsid proteins in the capsid segments are larger for the systems in which the NPs bind at the interfaces of capsid proteins. Over time, NP binding can lead to breaking of contacts between two neighboring proteins. The revealed mechanism of NPs targeting the interfaces between pairs of capsid proteins can be utilized for designing new generations of virucidal materials and contribute to the development of new broad-spectrum non-toxic virucidal materials.

Indexed as

CapsidNanoparticlesAntiviral AgentsCapsid ProteinsComputer SimulationHumansAntiviral AgentsCapsid Proteins

Identifiers

PMID34845905
PMCPMC8926016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.